Deep within Lechuguilla Cave, a sprawling cavern system beneath the Chihuahuan Desert of New Mexico, scientists are studying ancient bacteria exhibiting resistance to modern antibiotics. The discovery, made in an area of the cave where more people have walked on the moon than have ventured, offers a potential glimpse into the origins of antibiotic resistance and could inform the development of new treatments.
The Lechuguilla Cave, extending 149 miles, plunges 1604 feet below the surface. Its isolation—sealed off from the surface for approximately six million years, with the most recent opening disappearing around 50,000 years ago—has created a unique environment for microbial life to evolve. “You can go in an entrance and travel for 16 hours in one direction before you get to the end of it,” explained Hazel Barton, a professor of geological sciences at the University of Alabama, who has mapped portions of the cave system. “So you’re a particularly, very, very long way from the entrance. You’re isolated, and there are places in that cave where more people have walked on the moon than have been in that area.”
Researchers have identified a non-pathogenic strain of bacteria, Paenibacillus sp LC231, first identified in 2012, that demonstrates resistance to multiple antibiotics currently used in human medicine. The bacteria, surviving in near-starvation conditions and complete darkness, have developed diverse survival strategies, including predation on other bacteria and extracting energy from rocks and the atmosphere. According to Barton, the cave environment fosters a “miniature world of terror” where bacteria compete for limited resources.
The discovery of antibiotic resistance in this isolated environment suggests that resistance genes are widespread in the microbial world, independent of the selective pressure created by modern antibiotic use. Gerry Wright, director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University, noted that similar resistance genes are found in disease-causing bacteria in clinical settings. This finding points to a vast reservoir of resistance genes existing in the environment.
In 2012, Barton cataloged 93 antibiotic-resistant bacteria strains collected from the cave, with some strains resistant to as many as 14 different antibiotics. The bacteria’s resistance mechanisms, honed over millennia of isolation, are now being studied for potential applications in developing new drugs and treatments. Scientists hope to understand how these ancient microbes circumvent antibiotics, potentially inspiring novel approaches to combatting antibiotic resistance in modern medicine.
Access to Lechuguilla Cave is restricted, requiring a permit from the National Park Service. Barton was among only 36 people granted permission to enter the cave in 2012. Research continues, with scientists returning to the cave to further investigate the unique microbial ecosystem and its potential for medical breakthroughs.
